Elixinol Global Ltd. (EXL:ASX; ELLXF:OTCQX) reported quarterly (Q4) revenue at US$8.57 million, up a very strong 14% over Q3. Full year revenue growth was up 121% from December 2017. We will have further analyst when the full earnings become available the end of February. Some Australian stocks pre-release a short “cash flow” number, before full earnings, offering a glimpse at critically important top-line sales. Our takeaway: Robust growth continues. Elixinol is heavily investing in materials and production capacity. We expect strong growth continues in 2019, and we project upcoming Q4 earnings will confirm: Elixinol is the fastest growing hemp/CBD company.
TORONTO , April 17, 2018 /CNW/ – Cannabis Growth Opportunity Corporation (the “Corporation”) (CGOC.CN) a cannabis focused investment corporation with both public and private cannabis holdings, announces it has invested in Jushi Inc., a well-funded US consolidator that takes direct ownership stakes in cannabis operators. Jushi and its affiliates have franchise agreements in Florida , Nevada , Michigan , Oregon and Illinois including a royalty agreement with OrganiGram Holdings Inc. (OGI.V) and a minority ownership in one of ten New York based medical cannabis companies.
“giant stone,” the foundation of heaven and earth.
Jushi and its industry-leading management team are building an integrated multi-state owner and operator of cannabis and hemp licenses across the United States. Jushi is focused on continuing to build a diverse multi-state portfolio of branded cannabis and hemp-derived assets through opportunistic investments and by internally pursuing licenses in attractive jurisdictions. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis and hemp ecosystem. By investing over $5 million in a high-tech hemp processing operation on the east side of Buffalo, NY, Jushi expects to create approximately 30-65 jobs in the area. The facility will house a state-of-the-art lab, allowing Sound Wellness to create advanced product formulations using CBD distillate, CBD isolate, and water-soluble CBD.
Sound Wellness will be launching its physician-formulated line of hemp-derived CBD products under the “MEND” brand name. The products will be available at the DENT Neurologic Institute at a discount to its patients.
Sound Wellness products, including MEND products, are expected to be launched in retail locations and available via ecommerce throughout the United States and abroad in 2019.
Paul Leach of Venture Property and Leasing, LLC applied for a Value-Added Agricultural Commodity Processing Facility on his property. The project is described as an industrial hemp CBD isolate processing facility.